• leader board size
Case Studies2020-11-19T22:10:23-08:00

Case Studies

LEEF Brands Reports Q2 2025 Financial Results

VANCOUVER – LEEF Brands Inc. disclosed its second-quarter financials, showing steady revenue gains offset by squeezed margins and ongoing losses. The company reported $8.7 million in revenue for the period ended June 30, a 10% ...

Canada’s Cannabis Industry Defies Economic Odds

TORONTO – In a striking contrast to Canada’s faltering economy, the legal Cannabis industry continues to flourish, bolstering the nation’s GDP while other sectors struggle. Statistics Canada reports that the licensed cannabis sector grew by ...

LEEF Brands Reports Q2 2025 Financial Results

VANCOUVER – LEEF Brands Inc. disclosed its second-quarter financials, showing steady revenue gains offset by squeezed margins and ongoing losses. The company reported $8.7 million in revenue for the period ended June 30, a 10% ...

Ontario Anticipates Record Cannabis Revenue

LOS ANGELES- In a landmark financial forecast, Ontario expects to garner over CA$379 million from its share of the federal cannabis duty for the fiscal year April 2024 to March 2025, marking a significant 22.2% ...

Delaware Expands Medical Cannabis Program Access

NEW YORK- Delaware lawmakers have passed a significant bill aimed at broadening access to the state's medical cannabis program. On Thursday, the Delaware Senate approved a proposal that grants healthcare providers the discretion to certify ...

Maryland Awards Social Equity Cannabis Licenses

LOS ANGELES- In a significant move by the Maryland Cannabis Administration, 174 social equity cannabis licenses were awarded through a lottery system, showcasing the state's commitment to diversity and inclusion within the burgeoning cannabis industry. ...

Organigram Announces Investment in Open Book Extracts

NEW YORK- Organigram Holdings, a Canadian cannabis company, announced a $2 million investment in North Carolina-based Open Book Extracts. This move signifies Organigram's entry into the U.S. cannabis market, facilitated by an investment from British ...

Algernon Pharmaceuticals Advances Research Program

LOS ANGELES – In a significant move that underscores its commitment to innovative medical research, Algernon Pharmaceuticals Inc. announced its decision to prioritize its AP-188 ("N,N-Dimethyltryptamine" or "DMT") stroke research program. This announcement follows the ...

Glass House Brands Report Revenue and Profits

LOS ANGELES- In a notable financial turnaround, Glass House Brands, a California-based cannabis producer and retailer, reported significant growth in its fourth-quarter earnings, leading to a record revenue of $160.8 million for the fiscal year ...

ICER Raises Concerns Over MDMA-Assisted Psychotherapy for PTSD

LOS ANGELES- The Institute for Clinical and Economic Review (ICER) has recently highlighted significant concerns regarding the clinical evidence behind MDMA-assisted psychotherapy (MDMA-AP) for post-traumatic stress disorder (PTSD), according to a draft evidence report. This ...

Psilera Strengthens Board with Neuroscience

TAMPA –Psilera, a biotechnology company specializing in novel treatments for complex neurological disorders, has announced the addition of Dr. Magali Haas, M.D., Ph.D., to its Board of Directors. Dr. Haas, with an illustrious career spanning ...

Subscribe To Our Newsletter

Go to Top